[
  {
    "ts": null,
    "headline": "CVS Health (CVS): Reassessing Valuation After Raised 2025–2026 Guidance and New AI Consumer Platform",
    "summary": "CVS Health (CVS) just put fresh numbers on the table, raising its outlook for 2025 and sketching out higher earnings in 2026, and investors are paying attention because this guidance is tied to tangible progress in Aetna, pharmacy benefits and a new AI driven consumer platform. See our latest analysis for CVS Health. The guidance upgrade has been matched by price action, with CVS delivering a roughly 79 percent year to date share price return and a 59 percent one year total shareholder...",
    "url": "https://finnhub.io/api/news?id=bd44f4e52099b3ee09ee036872bc2cdae2144304ee25f14dc0372dcf0f0c4970",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765480435,
      "headline": "CVS Health (CVS): Reassessing Valuation After Raised 2025–2026 Guidance and New AI Consumer Platform",
      "id": 137762431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) just put fresh numbers on the table, raising its outlook for 2025 and sketching out higher earnings in 2026, and investors are paying attention because this guidance is tied to tangible progress in Aetna, pharmacy benefits and a new AI driven consumer platform. See our latest analysis for CVS Health. The guidance upgrade has been matched by price action, with CVS delivering a roughly 79 percent year to date share price return and a 59 percent one year total shareholder...",
      "url": "https://finnhub.io/api/news?id=bd44f4e52099b3ee09ee036872bc2cdae2144304ee25f14dc0372dcf0f0c4970"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak",
    "summary": "As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents. Both CVS Pharmacy® stores and MinuteClinic® walk-in medical clinics in the area have vaccines available to help protect patients against measles.",
    "url": "https://finnhub.io/api/news?id=8284cc9c36f169ea9c2a0166090724f3a4902cf90ae265dc58e98ede55adfab0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765470600,
      "headline": "CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak",
      "id": 137758865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents. Both CVS Pharmacy® stores and MinuteClinic® walk-in medical clinics in the area have vaccines available to help protect patients against measles.",
      "url": "https://finnhub.io/api/news?id=8284cc9c36f169ea9c2a0166090724f3a4902cf90ae265dc58e98ede55adfab0"
    }
  },
  {
    "ts": null,
    "headline": "Is Molina Healthcare Stock Underperforming the Dow?",
    "summary": "As Molina Healthcare has lagged behind the Dow over the past year, analysts remain cautious about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=e734299efac92b9936405975f52f8a6b96f53d3d3fb75cf1782294b0e5f3d607",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765460532,
      "headline": "Is Molina Healthcare Stock Underperforming the Dow?",
      "id": 137758866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "As Molina Healthcare has lagged behind the Dow over the past year, analysts remain cautious about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=e734299efac92b9936405975f52f8a6b96f53d3d3fb75cf1782294b0e5f3d607"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector”",
    "summary": "CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer in the healthcare sector under CEO David Joyner and shot up another 2% today as management laid out some bullish long-term earnings targets.” […]",
    "url": "https://finnhub.io/api/news?id=6452a4d295403f060c6df0475d73cdb427b29c1281696a02ced425748c6aab32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765457770,
      "headline": "Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector”",
      "id": 137757051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer in the healthcare sector under CEO David Joyner and shot up another 2% today as management laid out some bullish long-term earnings targets.” […]",
      "url": "https://finnhub.io/api/news?id=6452a4d295403f060c6df0475d73cdb427b29c1281696a02ced425748c6aab32"
    }
  }
]